Business
The Novo Nordisk Foundation proposes new candidates for election as members of the Board of Directors of Novo Nordisk A/S
Earlier today, Novo Nordisk A/S announced that it has called for an extraordinary general meeting to elect new members to its Board of Directors. The Novo Nordisk Foundation agrees with this decision and is proposing new board members for election, including Lars Rebien Sørensen as Chair and Cees de Jong as Vice Chair of the Board of the company.
About this update from Novo Nordisk A/s Class B
[{"type":"text","content":"COPENHAGEN, Denmark, Oct. 21, 2025 /PRNewswire/ -- Earlier today, Novo Nordisk A/S announced that it has called for an extraordinary general meeting to elect new members to its Board of Directors. The Novo Nordisk Foundation agrees with this decision and is proposing new board members for election, including Lars Rebien Sørensen as Chair and Cees de Jong as Vice Chair of the Board of the company.","length":404,"tagName":"p"},{"type":"text","content":"At the extraordinary general meeting of Novo Nordisk A/S, which will be held on 14 November, the Foundation will propose the following for election to the company's board:","length":175,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Lars Rebien Sørensen, Chair","length":27,"tagName":"p"}]},{"val":[{"type":"text","content":"Cees de Jong, Vice Chair","length":24,"tagName":"p"}]},{"val":[{"type":"text","content":"Britt Meelby Jensen, Member","length":27,"tagName":"p"}]},{"val":[{"type":"text","content":"Mikael Dolsten, Member","length":22,"tagName":"p"}]},{"val":[{"type":"text","content":"Stephan Engels, Member","length":22,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":122,"olType":false},{"type":"text","content":"Kasim Kutay and the employee-elected board members Elisabeth Dahl Christensen, Liselotte Hyveled, Mette Bøjer Jensen and Thomas Rantzau will remain on the Board.","length":161,"tagName":"p"},{"type":"text","content":"Furthermore, the Foundation plans to propose Helena Saxon and one additional member for election to Novo Nordisk's Board at the company's Annual General Meeting on 26 March 2026.","length":186,"tagName":"p"},{"type":"text","content":"A description of each candidate's qualifications and status as an independent or non-independent board member can be found in the appendix to this press release.","length":165,"tagName":"p"},{"type":"text","content":"The Novo Nordisk Foundation Board proposes election of Lars Rebien Sørensen as Chair of Novo Nordisk A/S with the intention that he serves for a limited period of 2-3 years with two key objectives: The first is to support the new management of Novo Nordisk A/S in implementing its transformation plans and regaining the company's growth momentum. The second objective is to identify and appoint a new chair who can successfully lead the company into the 2030s...